Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Walsh

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bipolar Disorders|March 15, 2005
Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentationIzabela Kawa, Janet D Carter, Peter R Joyce, et al.
The American Journal of Pathology|February 18, 1998
Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibersJ C Pache, Y M Janssen, E S Walsh, et al.
Analytical Biochemistry|February 22, 2001
High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123C A Buser, C J Dinsmore, C Fernandes, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 30, 2019
Bacterial community structure and response to nitrogen amendments in Lake Shenandoah (VA, USA)G Reynoso, M R Smith, C P Holmes, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.
Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bipolar Disorders|March 15, 2005
Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentationIzabela Kawa, Janet D Carter, Peter R Joyce, et al.
The American Journal of Pathology|February 18, 1998
Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibersJ C Pache, Y M Janssen, E S Walsh, et al.
Analytical Biochemistry|February 22, 2001
High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123C A Buser, C J Dinsmore, C Fernandes, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferaseB W Trotter, A G Quigley, W C Lumma, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 30, 2019
Bacterial community structure and response to nitrogen amendments in Lake Shenandoah (VA, USA)G Reynoso, M R Smith, C P Holmes, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.
Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.
Pageof 3